Champions Oncology CSBR Cash Flow Statement (2010-2026)

NASDAQ CSBR
$4.74 +0.05 (+0.96%)
As of: Oct 19, 2026 · 3:59 PM EDT
Reported Financials

Champions Oncology Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jul 2026

Champions Oncology reported cash from operations of -$0.49M and free cash flow of -$0.55M for the quarter ended Jul 2026, down 182.0% year over year. This cash flow statement covers 65 quarters of results from Jul 2010 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Operating Activities
Net Income
0.28M0.79M-0.34M-0.32M-0.02M-2.44M-2.56M-2.57M-2.07M-2.53M-0.11M1.31M0.73M4.50M-1.84M-0.47M0.24M-0.28M-0.69M-0.43M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.35M0.40M0.57M0.53M0.56M0.58M0.58M0.45M0.48M0.48M0.46M0.45M0.40M0.40M0.39M0.36M0.36M0.34M0.32M0.31M
Share-based CompensationStock Comp.
0.13M0.31M0.19M0.21M0.12M0.33M0.21M0.42M0.05M0.38M0.26M0.26M0.01M0.26M0.13M0.21M0.25M0.42M0.36M0.77M
Gains from Sales and DivestituresGains Divest
-0.02M-0.35M-0.29M-0.02M-0.09M0.00M
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
0.29M0.13M-0.05M0.11M0.16M0.07M0.08M0.16M-0.07M-0.21M-0.04M0.05M-0.03M0.00M-0.03M0.07M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
0.50M0.37M1.13M-0.16M-0.28M-0.94M0.07M1.10M-1.15M0.25M1.79M-0.57M1.23M5.27M-4.50M-1.76M2.08M0.50M1.19M0.41M
Change in Account PayablesChange Payables
0.13M0.27M-0.80M-0.33M2.07M-0.31M1.04M0.42M-1.22M0.22M1.04M-0.57M-0.38M-0.19M-0.61M0.41M1.31M-0.44M1.27M-1.43M
Change in Accured ExpensesChange Accured Exp.
-0.07M0.12M0.39M-0.46M-0.29M0.36M0.24M-0.18M-0.07M0.41M-0.27M-0.06M0.14M0.03M0.29M-0.76M0.39M1.16M-0.75M0.08M
Change in Other Operating AssetsOther Assets Change
0.07M-0.16M0.84M0.08M0.15M0.10M0.80M0.22M-0.09M0.34M0.94M0.05M-0.10M0.15M0.93M0.16M0.49M0.03M0.52M0.42M
Change in Other Operating LiabilitiesOther Liabilities Change
0.90M2.56M1.27M0.06M-0.46M1.71M-0.51M-1.93M1.57M0.05M-1.55M-2.11M-0.42M0.36M4.19M-1.37M-2.56M-2.72M-1.55M0.49M
Other Working Capital ChangesOther WC Changes
0.83M2.72M0.44M-0.02M-0.61M1.61M-1.32M-2.14M1.66M-0.28M-2.49M-2.15M-0.32M0.21M3.26M-1.53M-3.05M-2.75M-2.08M0.07M
Cash from OperationsCash from Ops.
1.23M4.26M0.80M-0.20M3.29M1.57M-0.69M-3.99M0.59M-0.92M-1.82M0.31M-0.28M0.49M6.87M0.60M-1.74M-1.34M-2.00M-0.49M
Investing Activities
Capital ExpendituresCapex
0.57M0.41M0.51M0.75M0.60M0.75M0.76M0.67M0.08M0.09M0.00M0.09M0.04M0.25M0.05M0.24M0.04M0.24M0.06M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.57M-0.41M-0.51M-0.75M-0.60M-0.75M-0.76M-0.67M-0.08M-0.09M0.00M-0.09M-0.04M-0.25M-0.05M-0.24M-0.04M-0.24M-0.06M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.57M-0.41M-0.51M-0.75M-0.60M-0.75M-0.76M-0.67M-0.08M-0.09M0.00M-0.09M-0.04M-0.25M-0.05M-0.24M-0.01M-0.24M-0.06M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.07M0.03M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.02M0.02M
Non-Current Debt
-0.07M-0.03M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.02M-0.02M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.07M-0.03M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.02M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
0.12M0.07M0.02M0.09M0.00M0.01M0.24M0.00M0.28M0.04M0.01M0.02M0.21M0.00M0.05M
Shares Repurchased
0.07M0.60M0.03M
Net Shares Issued and RepurchasedNet Shares Issued
0.12M0.07M0.02M0.09M-0.08M-0.59M0.21M0.00M0.28M0.04M0.01M0.02M0.21M0.00M0.05M
Net Equity Issued and RepurchasedNet Equity Issued
0.12M0.07M0.02M0.09M-0.08M-0.59M0.21M0.00M0.28M0.04M0.01M0.02M0.21M0.00M0.05M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.12M0.07M0.02M0.09M-0.08M-0.59M0.13M-0.03M-0.04M-0.04M0.24M-0.03M-0.01M0.17M-0.04M-0.02M0.03M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
0.78M3.92M0.31M-0.95M2.77M0.82M-1.53M-5.25M0.64M-1.05M-1.85M0.27M-0.14M0.45M6.58M0.54M-1.81M-1.39M-2.26M-0.51M
Ending Cash Balance
4.78M8.70M9.01M8.06M10.83M11.65M10.12M4.87M5.51M4.47M2.62M2.89M2.75M3.20M9.79M10.33M8.52M7.13M4.87M4.36M
Free Cash FlowFCF
0.66M3.85M0.29M-0.95M2.68M0.82M-1.45M-4.66M0.51M-1.01M-1.81M0.31M-0.38M0.45M6.62M0.55M-1.98M-1.38M-2.24M-0.55M
Net Cash FlowNCF
0.78M3.92M0.31M-0.95M2.77M0.82M-1.53M-5.25M0.64M-1.05M-1.85M0.27M-0.14M0.45M6.58M0.54M-1.81M-1.39M-2.26M-0.51M

Champions Oncology Cash Flow Statement API

Pull Champions Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CSBR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY